Norditropin Nordiflex (Somatropin)

Somatropin, the active ingredient in Norditropin Nordiflex, is a growth hormone presented as an injectable solution for subcutaneous use. It is prescribed to treat growth hormone deficiency and related growth disorders in children and adults, including conditions such as Turner syndrome, Prader‑Willi syndrome, chronic renal insufficiency, and HIV‑associated wasting.

GNH USA supplies Norditropin Nordiflex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides cold‑chain logistics for biologic products.

Norditropin Nordiflex, a recombinant human growth hormone, is used in disorders where growth hormone pathways are deficient or impaired.

- Growth hormone deficiency in children: promotes linear growth and improves height velocity. - Turner syndrome: supports stature increase and body composition improvement. - Prader‑Willi syndrome: helps increase height and lean body mass. - Chronic renal insufficiency: aids growth in pediatric patients with renal disease. - Adult growth hormone deficiency: restores metabolic balance and improves quality of life. - HIV‑associated wasting: counteracts loss of lean body mass and improves nutritional status.

Common Side Effects: - Injection site pain or erythema. - Headache. - Joint or muscle aches. - Peripheral edema. - Transient hyperglycemia. - Nausea.

Serious or Rare Side Effects: - Intracranial hypertension. - Slipped epiphysis (growth plate fracture). - Severe allergic reactions (anaphylaxis). - Progression of pre‑existing malignancies. - Pancreatitis. - Abnormal growth of benign or malignant tumors.

Before initiating therapy, clinicians should assess baseline metabolic and endocrine status and monitor patients regularly. - Blood glucose monitoring: adjust antidiabetic therapy as needed. - Intracranial pressure: watch for headaches, visual changes, or vomiting. - Skeletal health: evaluate for scoliosis or slipped epiphysis. - Malignancy screening: avoid in active cancer or uncontrolled tumor. - Renal function: dose may need adjustment in severe renal impairment. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Somatropin may interact with several drug classes that affect glucose metabolism or hormone balance.

Major Interactions (Avoid): - High‑dose glucocorticoids: can antagonize growth‑promoting effects. - Insulin or oral hypoglycemics: may require dose adjustment due to altered glucose tolerance.

Moderate Interactions (Monitor Closely): - Estrogen‑containing contraceptives: may reduce IGF‑1 response. - Thyroid hormone replacement: monitor thyroid function tests. - Other anabolic agents: assess for additive effects on growth and metabolism.